Loading...
Should terminally ill patients have unrestricted access to experimental drugs that haven't completed safety trials? | dilemma.
dilemma
.
?
← Archive
June 2, 2026
Next dilemma in
19:53:34
Ethics
Should terminally ill patients have unrestricted access to experimental drugs that haven't completed safety trials?
Allow unrestricted access
or
Maintain safety protocols